Study tests potential new drug to reduce pain and symptoms of endometriosis

October 9, 2012

(Medical Xpress)—According to the Centers for Disease Control (CDC), endometriosis, a gynecological disorder in which cells from the uterus lining grow in other areas of the body, is the number one reason for a hysterectomy in women ages 18-35.  Current treatment options for endometriosis are severely limited by side effects of existing medications and surgical options have more risks.  A nationwide clinical trial is testing an investigational drug as a potential new option for patients with moderate to severe pain from this disease. 

The Violet Petal Study, funded by Abbott and led at UC San Diego by Sanjay Agarwal, MD, FACOG, with the Department of at UC San Diego School of Medicine, is currently recruiting patients to be part of the one to two year study to investigate the safety and effectiveness of the Elagolix. "Endometriosis can be an extremely painful disease, especially during a woman's menstrual cycle.  Many women find themselves debilitated during these bouts, and the disease can also cause pain during intercourse and increase infertility," said Agarwal, director of UC San Diego Health System's Center for Endometriosis Research and Treatment (CERT), a one of a kind, multidisciplinary program in Southern California for women suffering from endometriosis.  

Common therapies include injections, which bring estrogen down to very low levels, resulting in side effects such as hot flashes, and .

"Many patients have to take a secondary medication to counteract the side effects from current treatment options," said Agarwal.  "The hope with Elagolix, taken daily, is to suppress estrogen just enough to take away the pain associated with endometriosis but without the harsh side effects to the body."

About five to 10 percent of women of reproductive age have endometriosis. The growths caused by the disease can cause tissue implants on the ovaries, bowel, rectum, bladder, and on the lining of the pelvic area. There is no cure for endometriosis and women usually need to be on treatment until menopause. 

As director of CERT, Agarwal brings together a broad team of clinical and scientific experts to work with endometriosis and look at different treatment options that will improve the quality of life for patients. 

"The Violet Petal Study will hopefully lead to a gentler treatment option for women living with endometriosis and advance our knowledge of this chronic disease," said Agarwal.

Eligible patients for the study must be between the ages of 18-49 and have been surgically diagnosed with in the last seven years.

For more information on the violet petal study, please visit: www.violetpetalstudy.com/HomePage.aspx

Explore further: Reproductive disorder linked to increased risk of inflammatory bowel disease

Related Stories

Reproductive disorder linked to increased risk of inflammatory bowel disease

December 20, 2011
Women with endometriosis are up to twice as likely to develop inflammatory bowel disease as those without this reproductive disorder, suggests a large study published online in Gut.

First study investigating possible link between sunscreen ingredient and endometriosis

May 9, 2012
Scientists are reporting a possible link between the use of sunscreen containing a certain ingredient that mimics the effects of the female sex hormone estrogen and an increased risk of being diagnosed with endometriosis, ...

Study suggests women with severe forms of endometriosis are more attractive

September 24, 2012
(Medical Xpress)—In a truly odd study undertaken by a group of OB/GYN researchers in Italy, volunteer women were judged to determine if a medical condition known as endometriosis causes those afflicted to be viewed as more ...

Recommended for you

Study in mice finds dietary levels of genistein may adversely affect female fertility

November 14, 2017
Exposure to the phytoestrogen genistein prior to conception may adversely affect female fertility and pregnancy outcomes, depending on the dosage and duration of exposure, a new study in mice suggests.

IUDs may have a surprising benefit: Protection against cervical cancer

November 7, 2017
Considered a safe and highly effective contraception method, intrauterine devices (IUDs) may also be quietly offering protection against the third-most common cancer in women worldwide. A new study from the Keck School of ...

Increasing rates of chronic conditions putting more moms, babies at risk

November 7, 2017
Pregnant women today are more likely to have chronic conditions that could cause life-threatening complications than at any other time in the past decade - particularly poor women and those living in rural communities, a ...

First time mums with an epidural who lie down more likely to have a normal birth

October 18, 2017
Adopting a lying down position rather than being upright in the later stages of labour for first-time mothers who have had a low dose epidural leads to a higher chance of them delivering their baby without any medical intervention, ...

Mice delivered by C-section gain more weight than those delivered naturally

October 11, 2017
Mice born by Caesarian section gained on average 33 percent more weight in the 15 weeks after weaning than mice born vaginally, with females gaining 70 percent more weight.

Study shows epidurals don't slow labor

October 10, 2017
Epidural analgesia - a mix of anesthetics and narcotics delivered by catheter placed close to the nerves of the spine - is the most effective method of labor pain relief. In widespread use since the 1970s, epidurals have ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.